top of page
Search

Gut Health: Exploring the Link Between Gut Health and Pancreas Cancer

  • Writer: Dr. Hansra
    Dr. Hansra
  • 11 hours ago
  • 5 min read

Pancreatic cancer or pancreatic ductal adenocarcinoma (PDAC) ranks as the 12th most incident cancer and the seventh cause of cancer-related death worldwide, accounting for around 496,000 new cases and 466,000 deaths annually (Sung et al., 2021), with incidence and mortality being predicted to nearly duplicate in 2040 due to demographic changes (Ferlay et al., 2020).



Risk Factors for Pancreas Cancer


Risk factors include smoking, chronic pancreatitis, diabetes mellitus, obesity, and genetic predisposition, yet the majority of cases arise sporadically without identifiable hereditary syndromes (Gualtieri et al., 2023; Sobocki et al., 2021). Accumulating evidence demonstrates that microbial dysbiosis, defined as alterations in microbiome composition and function, plays a causal role in pancreatic carcinogenesis (Suresh et al., 2025; Wang et al., 2019).


Gut Health and Pancreas Cancer Link


Patients with pancreatic ductal adenocarcinoma exhibit profound alterations in gut microbiome composition compared to healthy controls, characterized by reduced microbial diversity and distinct taxonomic shifts (Wang et al., 2019; Cheng et al., 2026). For example, several studies have reported Bacteroidetes overgrowth as a hallmark of PDAC-associated dysbiosis (Zebboudj et al., 2022; Wang et al., 2019). Other pro-inflammatory bacteria have been linked to PDAC including Porphyromonas gingivalis, a periodontal pathogen (Tabrizi et al., 2024; Wang et al., 2019). Fusobacterium nucleatum, another oral pathogen implicated in colorectal carcinogenesis, is similarly enriched in PDAC and promotes tumor progression through multiple mechanisms (Tabrizi et al., 2024; Wang et al., 2019). Also, research indicates that PDAC patients exhibit less microbial diversity with loss of beneficial organisms when compared to healthy controls (Li et al., 2020; Suresh et al., 2025). The loss of microbial diversity and beneficial bacteria creates a permissive environment for pathogen colonization, metabolic dysfunction, and immune dysregulation all of which facilitate the development of pancreatic cancer (Suresh et al., 2025; Zhang et al., 2022).


Gut health and pancreas cancer link
Gut health and pancreas cancer link


Dietary Factors and Gut Health in Pancreatic Cancer Risk


Dietary fiber intake profoundly influences gut microbiome composition and metabolic activity, with high-fiber diets associated with reduced cancer risk across multiple malignancies (Gualtieri et al., 2023; Panebianco et al., 2020). Fiber serves as the primary substrate for microbial fermentation, yielding SCFAs that exert anti-inflammatory and anti-proliferative effects (Gualtieri et al., 2023; Pacheco-Barcia et al., 2025). Epidemiological studies consistently demonstrate inverse associations between dietary fiber intake and pancreatic cancer risk, with high-fiber diets conferring protective effects (Gualtieri et al., 2023; Sobocki et al., 2021). These benefits likely result from combined effects on microbiome composition, SCFA production, glycemic control, and reduced systemic inflammation (Gualtieri et al., 2023). Also, there is emerging evidence for ketogenic diet (Lee et al., 2025; Sobocki et al., 2021), fasting-mimicking diet, and protein restriction (Dong et al. 2019) in protection against PDAC.


According to research high fiber diet can potentially lower cancer risk
According to research high fiber diet can potentially lower cancer risk

Western dietary patterns characterized by high intake of processed foods, red meat, refined carbohydrates, and low fiber—promote dysbiosis and increase pancreatic cancer risk (Gualtieri et al., 2023; Sobocki et al., 2021). Processed foods contain additives, emulsifiers, and artificial sweeteners that disrupt gut microbiome composition and intestinal barrier function (Gualtieri et al., 2023).


Alcohol consumption promotes dysbiosis, increases intestinal permeability, and induces chronic pancreatitis a major risk factor for PDAC (Sobocki et al., 2021). Alcohol-associated dysbiosis increases production of acetaldehyde and other carcinogenic metabolites while depleting protective bacteria (Sobocki et al., 2021).


There is ongoing research on gut health and pancreatic cancer treatment including exploring chemotherapy resistance, radiation therapy, immunotherapy, and surgery. Clinical trials are ongoing. The gut microbiome is emerging as a determinant of pancreatic cancer pathogenesis, progression, and therapeutic response, representing a paradigm shift in our understanding of this lethal malignancy. Many research gaps persist, including incomplete mechanistic understanding, questions of causality versus consequence.


For information on signs and symptoms of pancreas cancer check out:


For information on modifiable risk factors for pancreas cancer check out:



Conclusion


Pancreatic cancer remains a deadly cancer with generally poor prognosis. Identifying modifiable risk factors and engaging in healthy lifestyle can reduce your risk based on available evidence. Dietary factors can influence pancreas cancer risk, with high-fiber diets demonstrating protective effects through microbiome modulation. Conversely, Western dietary patterns, processed foods, and alcohol promote dysbiosis and increase cancer risk, so it is best to minimize these habits. Also check out my prior blog post detailing modifiable risk factors for pancreas cancer. Always see your healthcare provider to assess your risk of pancreas cancer.



References:

  1. Cheng, Y., Zhang, L., & Wang, W. (2026). Gut microbiota and pancreatic cancer: Tumorigenesis, progression, and clinical applications. Cancer Biology & Medicine, 23(2), 650-668.

  2. Dong, S., Liang, S., Cheng, Z., Zhang, X., Luo, L., Li, L., Zhang, W., Li, S., Xu, Q., Zhong, M., Hao, J., Zhang, Y., Zhang, L., Zhang, L., & Xu, Z. (2019). Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity. American Journal of Physiology-Gastrointestinal and Liver Physiology, 317(6), G763-G775.

  3. Ferlay J., Laversanne M., Ervik M., Lam F., Colombet M., Mery L., Piñeros M., Znaor A., Soerjomataram I. Global Cancer Observatory: Cancer Tomorrow. Lyon, France: International Agency for Research on Cancer. 2020.

  4. Gualtieri, P., Marchetti, M., Frank, G., Cianci, R., & De Lorenzo, A. (2023). Pancreatic ductal adenocarcinoma and nutrition: Exploring the role of diet and gut health. Nutrients, 15(20), 4465.

  5. Lee, H. S., Lee, J. W., Chang, H. M., Kim, T. W., Lee, J. S., & Kang, Y. K. (2025). Abstract B094: Ketogenic diet modulates gut microbiome composition and enhances treatment response in patients with advanced pancreatic cancer: A phase II study. Cancer Research, 85(3_Supplement), B094.

  6. Li, Q., Jin, M., Liu, Y., & Jin, L. (2020). Gut microbiota: Its potential roles in pancreatic cancer. Frontiers in Cellular and Infection Microbiology, 10, 572492.

  7. Li, X., Zhang, S., Guo, G., Han, J., & Yu, J. (2024). Fasting-mimicking diet prevents pancreatic carcinogenesis via gut microbiota and metabolites. Journal of Agricultural and Food Chemistry, 72(42), 23285-23297.

  8. Pacheco-Barcia, V., Muñoz-Unceta, N., Soriano, V., & Ghanem, I. (2025). Gut microbiome and nutritional strategies in gastrointestinal cancers: Clinical implications and therapeutic perspectives. World Journal of Clinical Oncology, 16(10), 107877.

  9. Panebianco, C., Villani, A., Pazienza, V., Palmieri, O., Carella, M., Bonfiglio, C., Fontana, A., Panza, F., Petruzzi, J., Bagnardi, V., Andriulli, A., & Pazienza, V. (2020). Engineered resistant-starch (ERS) diet shapes colon microbiota profile in parallel with the retardation of tumor growth in in vitro and in vivo pancreatic cancer models. Nutrients, 12(2), 331.

  10. Sobocki, B. K., Kazmierczak-Siedlecka, K., Folwarski, M., Hawrylkowicz, V., Makarewicz, W., & Lebiedzinska, A. (2021). Pancreatic cancer and gut microbiome-related aspects: A comprehensive review and dietary recommendations. Nutrients, 13(12), 4425.

  11. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA. Cancer J. Clin. 2021;71:209–249.

  12. Tabrizi, S., Nikou, M., Valipour, E., Parvizi, F., Mirfakhraie, R., & Madjd, Z. (2024). Unraveling the gut microbiome's contribution to pancreatic ductal adenocarcinoma: Mechanistic insights and therapeutic perspectives. Frontiers in Immunology, 15, 1434771.

  13. Wang, H., Zhang, X., & Wang, J. (2019). Role of the microbiome in occurrence, development and treatment of pancreatic cancer. Molecular Cancer, 18(1), 173.

  14. Zebboudj, A., Magen, A., Lagrue, K., Corgnac, S., Mezquita, L., Lahmar, J., Viaud, S., Pitt, J. M., Iebba, V., Mariat, D., Segata, N., Derosa, L., Zitvogel, L., & Routy, B. (2022). 1312 Gut dysbiosis suppresses anti-tumor ILC2s in pancreatic cancer. Journal for ImmunoTherapy of Cancer, 10(Suppl 2), A1366.

  15. Zhang, Y., Tan, X., Cao, Y., An, X., Chen, J., & Yang, L. (2022). Gut dysbiosis in pancreatic diseases: A causative factor and a novel therapeutic target. Frontiers in Nutrition, 9, 814269.


Disclaimer:


As a service to our readers, Smart and Easy Health.com provides access to our library of archived content. Please note the date of last review on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

 
 
 

Comments

bottom of page